All data are based on the daily closing price as of March 10, 2026
g

Grape King Bio

1707.TW
3.83 USD
0.11
+2.96%

Overview

Last close
3.83 usd
Market cap
567.03M usd
52 week high
4.87 usd
52 week low
3.72 usd
Target price
5.39 usd

Valuation

P/E
14.7741
Forward P/E
17.3611
Price/Sales
1.7228
Price/Book Value
1.7582
Enterprise Value
466.92M usd
EV/Revenue
1.4244
EV/EBITDA
5.1628

Key financials

Revenue TTM
327.79M usd
Gross Profit TTM
248.01M usd
EBITDA TTM
84.95M usd
Earnings per Share
0.26 usd
Dividend
N/A usd
Total assets
501.40M usd
Net debt
-125.83M usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care. It also provides functional ingredients for intestinal care, weight control, liver care, brain health, eye care, feminine health, and sensual health care; and microbial fermentation, as well as food inspection services. In addition, the company offers health foods, beverages, cosmetics, and general and pet food. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top